| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |